Spots Global Cancer Trial Database for unresectable gallbladder cancer

Every month we try and update this database with for unresectable gallbladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder	NCT00084942	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	Roswell Park Cancer Institute
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs	NCT06423170	Unresectable Ga...	Camrelizumab pl...	18 Years - 75 Years	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer	NCT00003411	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	motexafin gadol... radiation thera...	18 Years - 120 Years	University of Pittsburgh
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer	NCT00107536	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer	NCT00073905	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain	capecitabine pl...	18 Years - 80 Years	Swiss Group for Clinical Cancer Research
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer	NCT00003427	Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine...	irinotecan hydr... oxaliplatin	18 Years -	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer	NCT00009893	Extrahepatic Bi... Gallbladder Can... Liver Cancer	fluorouracil gemcitabine hyd... leucovorin calc...	18 Years - 120 Years	Alliance for Clinical Trials in Oncology
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder	NCT00085410	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Gastrointestina... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	bortezomib	18 Years -	National Cancer Institute (NCI)
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs	NCT06423170	Unresectable Ga...	Camrelizumab pl...	18 Years - 75 Years	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers	NCT01229111	Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Periampullary A... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	cediranib malea... oxaliplatin leucovorin calc... fluorouracil	18 Years -	National Cancer Institute (NCI)
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy	NCT00896467	Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine...	questionnaire a... psychosocial as... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery	NCT00101036	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer	NCT00486356	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu...	capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological...	18 Years - 120 Years	University of Nebraska
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery	NCT00513539	Extrahepatic Bi... Gallbladder Can...	porfimer sodium biliary stentin...	18 Years -	University College, London
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery	NCT00478140	Adenocarcinoma ... Adenocarcinoma ... Malignant Neopl... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	trastuzumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer	NCT00027534	Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ...	TRICOM-CEA(6D)	18 Years -	Duke University
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer	NCT00009893	Extrahepatic Bi... Gallbladder Can... Liver Cancer	fluorouracil gemcitabine hyd... leucovorin calc...	18 Years - 120 Years	Alliance for Clinical Trials in Oncology
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer	NCT00397384	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Carcinoma of th... Gastrointestina... Metastatic Gast... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Pancr... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Pancre... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Unresectable Ex... Unresectable Ga...	cetuximab erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer	NCT00073905	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain	capecitabine pl...	18 Years - 80 Years	Swiss Group for Clinical Cancer Research
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs	NCT06423170	Unresectable Ga...	Camrelizumab pl...	18 Years - 75 Years	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer	NCT00658593	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Canadian Cancer Trials Group
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer	NCT00658593	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Canadian Cancer Trials Group
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer	NCT00003557	Extrahepatic Bi... Gallbladder Can... Liver Cancer	dolastatin 10	18 Years -	University of Chicago
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer	NCT00059865	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... pemetrexed diso...	18 Years -	Alliance for Clinical Trials in Oncology
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors	NCT00262769	Extrahepatic Bi... Gallbladder Can...	cisplatin gemcitabine hyd...	16 Years -	University College, London
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery	NCT00101036	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer	NCT00107536	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer	NCT00987766	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc... Periampullary A... Small Intestine...	erlotinib hydro... gemcitabine hyd... oxaliplatin laboratory biom...	18 Years -	Vanderbilt-Ingram Cancer Center
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas	NCT00003923	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc...	porfimer sodium	18 Years -	Memorial Sloan Kettering Cancer Center
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder	NCT00085410	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Gastrointestina... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	bortezomib	18 Years -	National Cancer Institute (NCI)
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients	NCT00253383	Cancer	counseling inte... educational int... psychosocial as... quality-of-life...	18 Years -	Dartmouth-Hitchcock Medical Center
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer	NCT00055705	Cancer	PV701	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer	NCT00096083	Cancer	isolated perfus... melphalan	16 Years -	Delcath Systems Inc.
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery	NCT00478140	Adenocarcinoma ... Adenocarcinoma ... Malignant Neopl... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	trastuzumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: